In addition to BC, the following malignancies were detected in five carriers of CHEK2 pathogenic or likely pathogenic germline variants: pancreatic cancer, uterine cancer, prostate cancer, bladder cancer, multiple myeloma, kidney cancer, colon cancer, and thyroid carcinoma. Here, CHEK2 is linked to urinary bladder carcinoma.